-+ 0.00%
-+ 0.00%
-+ 0.00%

vTv Therapeutics Q2 EPS $(0.92) Misses $(0.82) Estimate.

Benzinga·08/12/2025 20:17:40
Listen to the news
vTv Therapeutics (NASDAQ:VTVT) reported quarterly losses of $(0.92) per share which missed the analyst consensus estimate of $(0.82) by 11.52 percent. This is a 13.58 percent decrease over losses of $(0.81) per share from the same period last year.